Regulatory Intelligence & Monitoring Platform

Stay Ahead of Regulatory Changes That Impact Your Pharmacy

AI-powered regulatory monitoring and intelligence for compounding pharmacies and peptide operators. Monitor FDA, DEA, USP, Federal Register and State Board updates in one place.

Book a Discovery Call Join the Regulatory Watch Newsletter

6+: Regulatory source categories
24/7: Continuous monitoring
100%: Alerts source-cited

The Problem

Regulatory Changes Are Constant. Monitoring Them Isn't Your Full-Time Job.

Most operators track regulation the same way: a few bookmarked pages, a couple of listservs, and whoever happens to notice something first. It works until it doesn't — and the miss shows up in an inspection, not in an inbox.

FDA announcements & guidance

Published on its own schedule, in its own format, with no alert when it changes.

DEA notices & scheduling actions

Published on its own schedule, in its own format, with no alert when it changes.

USP <795> / <797> / <800> updates

Published on its own schedule, in its own format, with no alert when it changes.

State Board of Pharmacy bulletins

Published on its own schedule, in its own format, with no alert when it changes.

Federal Register rulemaking

Published on its own schedule, in its own format, with no alert when it changes.

Industry & association guidance

Published on its own schedule, in its own format, with no alert when it changes.

Fragmented manual monitoring doesn't just cost hours — it creates a gap between when a rule changes and when your operation knows about it. That gap is the risk.

The Platform

One Platform. Every Critical Regulatory Update.

01

Monitor Sources

02

AI Analysis

03

Human Validation

04

Actionable Alerts

Continuous monitoring

Dozens of federal, state, and industry sources tracked around the clock so nothing depends on someone remembering to check.

Relevance scoring

Every item is scored against your facility type, dosage forms, and state footprint — you see what applies to you.

Plain-English summaries

Rulemaking language translated into a few sentences a pharmacy owner or DOP can act on immediately.

Impact assessments

What it touches: sterile operations, labelling, sourcing, recordkeeping, or licensure — with a recommended next step.

Source citations

Every alert links back to the primary publication, so your compliance file is defensible from day one.

Effective-date tracking

Comment windows and compliance deadlines surfaced early enough to actually respond to them.

How It Works

From published rule to decision on your floor.

01
Monitor Regulatory Sources
FDA, DEA, USP, the Federal Register, and State Boards are ingested continuously — federal and state, in one pipeline.
02
Identify Relevant Changes
Each item is filtered against your profile so 503A, 503B, and clinic operators only see what touches their operation.
03
Summarise Impact
Analysis produces a plain-English summary, a why-it-matters read, and the operational areas affected.
04
Deliver Alerts
Priority alerts arrive by email and in-platform, with a weekly digest for everything of lower urgency.
05
Support Better Decisions
Recommended actions, source links, and a searchable history give your team a defensible record of what you knew and when.

Sample Alert

This is what lands in your inbox.

No digest to wade through, no regulatory language to decode. One change, why it matters to your operation, what to do about it, and the source it came from.

See it weekly — join Regulatory Watch

Priority alert · FDA

High relevance

FDA Adds XYZ Peptide To Compounding Concern List

Why It MattersMay impact 503A sterile compounding operations that currently prepare or stock this ingredient for office use.

Recommended ActionReview inventory and labelling processes, confirm sourcing documentation, and flag affected prescriptions for pharmacist review.

Affected AreasSterile compounding · Inventory · Labelling · Recordkeeping

SourceFDA publication

Illustrative example · Reviewed by a human before delivery

About Curt

Building the intelligence layer for peptides and compounding.

Curt Bigelow — Founder, Growth Alchemy

42+ years working inside highly regulated, high-stakes environments — 20 years in aerospace and defense operations, followed by 22 years consulting globally across complex, compliance-driven programs. Precision, risk awareness, and systems thinking are the default, not an add-on.

That discipline now goes into infrastructure for the peptide and compounding industry: monitoring the sources that govern this market, and turning regulatory movement into something an operator can actually act on.

Curt's understanding of the performance and peptide market is firsthand — nine NPC competitions across four states and two national stages over five years. He knows the claims, expectations, and scrutiny operators in this space navigate daily.

"You don't rise to the moment — you fall to your systems. Let's make sure yours are built for what's coming."

Areas of Expertise

Peptide & compounding market knowledge
Regulatory awareness in high-stakes environments
Operational compliance frameworks
AI and technology implementation
Systems thinking & risk modelling
Executive advisory & leadership development

Early Access

Become An Early Access Partner

We are currently working with a select group of pharmacies and operators to help shape the future of regulatory intelligence.

Early access
Use the platform before general availability.
Direct influence
Your workflow shapes what gets built next.
Founding pricing
Locked-in partner rate as the product grows.
Priority support
Direct line to the founder, not a ticket queue.

FAQ

Questions, answered.

Stop Missing Regulatory Changes That Matter

Join the growing number of operators taking a proactive approach to regulatory intelligence.

Book A Discovery Call Join Regulatory Watch

Free · 30 minutes · No obligation